These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Non-HFE hemochromatosis: pathophysiological and diagnostic aspects. Bardou-Jacquet E; Ben Ali Z; Beaumont-Epinette MP; Loreal O; Jouanolle AM; Brissot P Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):143-54. PubMed ID: 24321703 [TBL] [Abstract][Full Text] [Related]
3. Successful Treatment of Iron-Overload Cardiomyopathy in Hereditary Hemochromatosis With Deferoxamine and Deferiprone. Tauchenová L; Křížová B; Kubánek M; Fraňková S; Melenovský V; Tintěra J; Kautznerová D; Malušková J; Jirsa M; Kautzner J Can J Cardiol; 2016 Dec; 32(12):1574.e1-1574.e3. PubMed ID: 27789107 [TBL] [Abstract][Full Text] [Related]
4. Iron deficiency and overload. Beutler E; Hoffbrand AV; Cook JD Hematology Am Soc Hematol Educ Program; 2003; ():40-61. PubMed ID: 14633776 [TBL] [Abstract][Full Text] [Related]
5. Reversal of end-stage heart failure in juvenile hemochromatosis with iron chelation therapy: a case report. Cooray SD; Heerasing NM; Selkrig LA; Subramaniam VN; Hamblin PS; McDonald CJ; McLean CA; McNamara E; Leet AS; Roberts SK J Med Case Rep; 2018 Jan; 12(1):18. PubMed ID: 29373985 [TBL] [Abstract][Full Text] [Related]
6. Management of cardiac hemochromatosis. Aronow WS Arch Med Sci; 2018 Apr; 14(3):560-568. PubMed ID: 29765443 [TBL] [Abstract][Full Text] [Related]
8. Cardiac iron overload following liver transplantation in patients without hereditary hemochromatosis or severe hepatic iron deposition. Papadodima S; Masia R; Stone JR Cardiovasc Pathol; 2019; 40():7-11. PubMed ID: 30763826 [TBL] [Abstract][Full Text] [Related]
13. The mechanisms of systemic iron homeostasis and etiology, diagnosis, and treatment of hereditary hemochromatosis. Kawabata H Int J Hematol; 2018 Jan; 107(1):31-43. PubMed ID: 29134618 [TBL] [Abstract][Full Text] [Related]
14. HJV hemochromatosis, iron overload, and hypogonadism in a Brazilian man: treatment with phlebotomy and deferasirox. Santos PC; Cançado RD; Pereira AC; Chiattone CS; Krieger JE; Guerra-Shinohara EM Acta Haematol; 2010; 124(4):204-5. PubMed ID: 21071928 [No Abstract] [Full Text] [Related]
15. An Iron-chelating Agent Improved the Cardiac Function in a Patient with Severe Heart Failure Due to Hereditary Hemochromatosis. Setoguchi A; Kawano H; Okano S; Honda T; Kato T; Dateki S; Senoo A; Nakashima Y; Motokawa T; Ueno Y; Akashi R; Yonekura T; Sueyoshi E; Ikeda S; Miyazaki Y; Maemura K Intern Med; 2024 Jan; 63(2):253-258. PubMed ID: 37197964 [TBL] [Abstract][Full Text] [Related]